Intermune Pharmaceuticals, Inc.

Burlingame, CA 94010

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $309K
First Award Date 09/30/01
Most Recent Award Date 01/01/02

Key Personnel

Last Name Name Awards Contact
Sawa Teiji Sawa 1
Spack Edward G Spack 1

2 Awards Won

Phase 1 STTR

Agency: Department of Health & Human Services
Budget: 01/01/02 - 06/30/03

DESCRIPTION (provided by applicant): This grant will determine the efficacy of a humanized monoclonal antibody in treating a lethal Pseudomonas-induced lung injury. We have shown that the airspace instillation of a strain of Pseudomonas aeruginosa that contains the type Il system predictably causes lung necrosis, sepsis ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Budget: 09/30/01 - 03/31/03

DESCRIPTION (provided by applicant): We propose an innovative approach to prevent Pseudomonas aeruginosa infection by blockade of a critical Type III secretory protein with monoclonal antibodies. Pseudomonas causes disease by the release of exotoxins which destroy host tissue and paralyze the phagocytic mechani...